The interaction of oncogene and tumour suppressor gene defects with cytotoxic drugs: its role in the improvement of selective toxicity and the development of new drugs in clinical oncology

R D Petty, Russell David Petty

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)186-9
Number of pages4
JournalClinical Oncology
Issue number3
Publication statusPublished - 1996


  • Antineoplastic Agents
  • Drug Design
  • Drug Resistance, Neoplasm
  • Genes, Tumor Suppressor
  • Genes, myc
  • Genes, p53
  • Genetic Therapy
  • Humans
  • Neoplasms
  • Oncogenes

Cite this